Article
Biotechnology & Applied Microbiology
Wenwen Ding, Danhua Zhou, Shimeng Zhang, Jiaping Qian, Lingxia Yang, Lei Tang
Summary: This study demonstrates that Trimetazidine (TMZ) can inhibit liver fibrosis and hepatic stellate cell proliferation induced by CCl4 and TGF-beta. TMZ exerts its effects by blocking the activation of TGF beta/Smad signaling pathway. These findings provide new insights into the potential application of TMZ in the treatment of liver fibrosis.
Article
Oncology
Kyungjoo Cho, Nam Hee Kim, Sang Hyun Seo, Sang Hyun Song, Chul Hee Jeong, Hyun Sil Kim, Jo Eun Um, Minhee Ku, Jaemoon Yang, Jun Yong Park, Sang Hoon Ahn, Jong In Yook, Seung Up Kim
Summary: In this study, a micelle formulation containing bone morphogenetic protein-7 (BMP-7) was designed and tested in a mouse liver fibrosis model. The results showed that the formulation effectively suppressed the signaling pathway of transforming growth factor-beta (TGF-beta), leading to improvement in liver fibrosis.
AMERICAN JOURNAL OF CANCER RESEARCH
(2022)
Article
Oncology
Alba Gonzalez-Junca, Oliver Reiners, Luis D. Borrero-Garcia, Denis Beckford-Vera, Ann A. Lazar, William Chou, Steve Braunstein, Henry VanBrocklin, Benjamin L. Franc, Mary Helen Barcellos-Hoff
Summary: The study investigates the potential of using PET imaging to detect TGF beta activation in tumors, showing that radiation therapy induces TGF beta activation, and TGF beta blockade provides survival benefit only in the context of radiation treatment.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
(2021)
Article
Pharmacology & Pharmacy
Aqsa Iqbal, Ulrike May, Stuart N. Prince, Tero A. H. Jarvinen, Ahlke Heydemann
Summary: Targeted delivery of therapeutic decorin through vascular homing peptide significantly reduces skeletal muscle fibrosis and pathology, while improving functional characteristics of skeletal muscle in mouse models of muscular dystrophy.
Article
Pharmacology & Pharmacy
Jie Huang, Yan Li, Dingwei Xu, Xiao Zhang, Xiaoyang Zhou
Summary: In this study, it was found that the expression of RUNX1 was upregulated in LF mice, and RUNX1 knockdown alleviated CCl4-induced LF. RUNX1 silencing reduced the viability and migration of HSCs. Besides, as a transcription factor, RUNX1 bound to the promoter of USP9X and regulated the expression of USP9X. USP9X, a deubiquitination enzyme, was found to be upregulated in LF mice. Silencing of USP9X reduced the viability and migration of HSCs, thereby inhibiting LF.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Article
Multidisciplinary Sciences
Yasmin Badshah, Maria Shabbir, Khushbukhat Khan, Maha Fatima, Iqra Majoka, Laiba Aslam, Huda Munawar
Summary: This study assessed the pathogenicity and prevalence of IL-6 and TGF beta-1 polymorphisms in HCV-infected HCC patients. Experimental and computational approaches were used to analyze the regulatory nature of these polymorphisms. The results showed that certain genotypes are associated with an increased risk of HCV-induced HCC.
Article
Multidisciplinary Sciences
Jeong-Rang Jo, Seungwon An, Swati Ghosh, Balachandar Nedumaran, Yong Deuk Kim
Summary: This study investigated the link between GH and the BTG2-YY1 signaling pathway in glucose metabolism, showing that GH treatment elevated Btg2 and Yy1 expression in the liver, leading to increased glucose production. The findings suggest that BTG2 and YY1 are novel regulators of GH-dependent regulation of hepatic gluconeogenic genes and glucose production.
SCIENTIFIC REPORTS
(2021)
Article
Cardiac & Cardiovascular Systems
Yanan Liu, Mengke Li, Xue Lv, Kaiwen Bao, Xiao Yu Tian, Lei He, Lei Shi, Yi Zhu, Ding Ai
Summary: The study reveals that YAP protein is upregulated in metabolic syndrome and leads to the activation of the TGF beta pathway, resulting in arterial stiffness. It is found that YAP inhibits the dephosphorylation of Smads through removal of the ubiquitin chain. These findings are significant for the development of therapeutic targets for metabolic syndrome-associated arterial stiffness.
CIRCULATION RESEARCH
(2022)
Review
Medicine, Research & Experimental
Qin-Yi Su, Sheng-Xiao Zhang, Liu Yang, Jing Luo, Xiao-Feng Li, Jia-Qi Zhang, Yan Zhang, Jun-Qi Liu, Lei Shi
Summary: There is controversy regarding the levels of T-reg cells in PsA patients. This meta-analysis aimed to clarify the status of T-reg cells in PsA patients. The results showed that PsA patients had alterations in T-reg cells, with a lower percentage of CD4(+) T-reg cells and a higher abundance of CD4(+)CD25(+)FoxP3(+) T-reg cells in synovial fluid. Additionally, PsA patients had decreased levels of the cytokine TGF-beta.
ADVANCES IN THERAPY
(2023)
Article
Biochemistry & Molecular Biology
Athanassios Fragoulis, Julia Schenkel, Nicole Schroeder, Elisa Fabiana Brandt, Mathias Weiand, Tabita Neu, Pierluigi Ramadori, Tim Caspers, Sebastian Kant, Thomas Pufe, Antje Mohs, Christian Trautwein, Thomas Longerich, Konrad Ludwig Streetz, Christoph Jan Wruck
Summary: The Nrf2 signaling pathway plays a dual role in cancer, both preventing initiation and being involved in various types of cancer. In this study, sustained Nrf2 activation was found to induce proliferation and dedifferentiation of hepatic progenitor cells, transforming them into metastatic cancer cells similar to hepatoblastoma. The upregulation and activation of beta-catenin were identified as the underlying mechanism for this malignant transformation. These findings highlight the importance of the Nrf2-beta-catenin axis in promoting proliferation of hepatic stem cells and triggering tumorigenesis.
Article
Oncology
Xin Yuan, Ling Zhang, Jianlin Du
Summary: It has been shown that Tbx18-positive cells contribute to the development of the urinary system, particularly renal fibroblasts. Under pathological conditions induced by UUO, Tbx18-positive cells may act as profibrotic progenitors, with TGF-beta potentially playing a role in their differentiation into myofibroblasts in kidney fibrosis.
EXPERIMENTAL CELL RESEARCH
(2021)
Article
Cell Biology
Nathalie G. M. Thielen, Margot Neefjes, Elly L. Vitters, Henk M. van Beuningen, Arjen B. Blom, Marije I. Koenders, Peter L. E. M. van Lent, Fons A. J. van de Loo, Esmeralda N. Blaney Davidson, Arjan P. M. van Caam, Peter M. van der Kraan
Summary: During osteoarthritis, TGF-beta signaling pathways contribute to the hypertrophy-like phenotype in chondrocytes. This study found that ALK5 kinase activity is essential for the induction of crucial hypertrophy factors in TGF-beta-stimulated chondrocytes.
Article
Biochemistry & Molecular Biology
Yi-Chuang Xu, Hua Zheng, Christer Hogstrand, Xiao-Ying Tan, Tao Zhao, Yu-Feng Song, Xiao-Lei Wei, Li-Xiang Wu, Zhi Luo
Summary: Zinc plays an important regulatory role in lipid metabolism by promoting lipolysis, inhibiting lipogenesis, and controlling the beta-catenin signal. The study reveals the significant roles of the HDAC3/beta-catenin pathway in zinc-induced lipolysis and inhibition of lipogenesis.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
(2023)
Article
Oncology
Hongkun Cai, Feng Guo, Shuang Wen, Xin Jin, Heshui Wu, Dianyun Ren
Summary: The study found that abnormal KRAS activation in pancreatic cancer led to ITGA2 overexpression, which in turn suppressed the activation of the TGF-beta pathway. Mechanistically, ITGA2 inhibited the activation of the TGF-beta pathway by transcriptionally inhibiting SMAD2 expression. Additionally, ITGA2 interacted with TFCP2, inhibiting its nuclear translocation and affecting the expression of SMAD2.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2022)
Article
Hematology
Cristina Arce, Isaac Rodriguez-Rovira, Karo De Rycke, Karina Duran, Victoria Campuzano, Isabel Fabregat, Francesc Jimenez-Altayo, Pedro Berraondo, Gustavo Egea
Summary: P144 can prevent the onset of aortic aneurysm in a Marfan syndrome mouse model, but does not stop its progression. P144 improves elastic fiber morphology and normalizes pERK1/2-mediated TGF beta signaling.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
(2021)
Article
Oncology
Snehal Dabir, Adam Kresak, Michael Yang, Pingfu Fu, Gary Wildey, Afshin Dowlati
MOLECULAR CANCER THERAPEUTICS
(2015)
Article
Cell Biology
E. F. Greenberg, K. S. McColl, F. Zhong, G. Wildey, A. Dowlati, C. W. Distelhorst
CELL DEATH & DISEASE
(2015)
Article
Oncology
Rime Abbas, Karen S. McColl, Adam Kresak, Michael Yang, Yanwen Chen, Pingfu Fu, Gary Wildey, Afshin Dowlati
Article
Oncology
A. Dowlati, M. B. Lipka, K. McColl, S. Dabir, M. Behtaj, A. Kresak, A. Miron, M. Yang, N. Sharma, P. Fu, G. Wildey
ANNALS OF ONCOLOGY
(2016)
Article
Oncology
Nneha Sakre, Gary Wildey, Mohadese Behtaj, Adam Kresak, Michael Yang, Pingfu Fu, Afshin Dowlati
Article
Oncology
Arnaud Augert, Qing Zhang, Breanna Bates, Min Cui, Xiaofei Wang, Gary Wildey, Afshin Dowlati, David MacPherson
JOURNAL OF THORACIC ONCOLOGY
(2017)
Article
Oncology
Karen McColl, Gary Wildey, Nneha Sakre, Mary Beth Lipka, Mohadese Behtaj, Adam Kresak, Yanwen Chen, Michael Yang, Vamsidhar Velcheti, Pingfu Fu, Afshin Dowlati
Article
Oncology
Sarmishtha De, Daniel J. Lindner, Claire J. Coleman, Gary Wildey, Afshin Dowlati, George R. Stark
Article
Oncology
Snehal Dabir, Amy Kluge, Karen McColl, Yu Liu, Minh Lam, Balazs Halmos, Gary Wildey, Afshin Dowlati
INTERNATIONAL JOURNAL OF CANCER
(2014)
Article
Oncology
Tian He, Karen McColl, Nneha Sakre, Yanwen Chen, Gary Wildey, Afshin Dowlati
MOLECULAR ONCOLOGY
(2018)
Article
Oncology
Priyanka Bhateja, Michelle Chiu, Gary Wildey, Mary Beth Lipka, Pingfu Fu, Michael Chiu Lee Yang, Fatemeh Ardeshir-Larijani, Neelesh Sharma, Afshin Dowlati
Article
Oncology
Tian He, Gary Wildey, Karen McColl, Alyssa Savadelis, Kyle Spainhower, Cassidy McColl, Adam Kresak, Aik Choon Tan, Michael Yang, Ata Abbas, Afshin Dowlati
Summary: RUNX1T1 gene amplification was specific to small cell tumors of c-SCLC patients but rare in 'pure' SCLC patients. Higher expression of RUNX1T1 was observed in SCLC compared to other cancers, including NSCLC. Additionally, stable RUNX1T1 overexpression led to significant changes in E2F targets and decreased CDKN1A (p21) expression in multiple lung cancer cell lines.
MOLECULAR ONCOLOGY
(2021)
Article
Oncology
Daniel J. Lindner, Gary Wildey, Yvonne Parker, Afshin Dowlati, George R. Stark, De Sarmishtha
Summary: The study investigated the potential effect of combining Rova-T and CBL in small cell lung cancer to eradicate tumor-initiating cells more effectively, presenting a novel therapeutic strategy for increasing survival rates in SCLC patients.
BRITISH JOURNAL OF CANCER
(2021)
Article
Oncology
Gary Wildey, Ashley M. Shay, Karen S. McColl, Suzy Yoon, Mohammad A. Shatat, Ahmad Perwez, Kyle B. Spainhower, Adam M. Kresak, MaryBeth Lipka, Michael Yang, Mohadese Behtaj, Pingfu Fu, Asrar Alahmadi, Wadad Mneimneh, Ata Abbas, Afshin Dowlati
Summary: Genomic studies have found that some small cell lung cancer (SCLC) tumors do not have RB1 mutations, contrary to the canonical model. This study examined RB1 protein expression and its function in SCLC and found that 14% of SCLC tumors expressed abundant RB1 protein, which was associated with neuroendocrine gene expression and enriched in YAP1 expression. SCLC cells with RB1 protein expression were sensitive to growth inhibition by the CDK4/6 inhibitor palbociclib, and a patient with wild-type RB1 SCLC showed a significant decrease in mutant TP53 ctDNA allelic fraction and tumor mass after treatment with the CDK4/6 inhibitor abemaciclib.
MOLECULAR CANCER THERAPEUTICS
(2023)
Editorial Material
Oncology
Gary Wildey, Afshin Dowlati
TRANSLATIONAL LUNG CANCER RESEARCH
(2016)